Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. (Record no. 30728072)

MARC details
000 -LEADER
fixed length control field 01692 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518091417.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202109s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1573-0646
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s10637-020-00918-1
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Viglietta, Vissia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210902
245 00 - TITLE STATEMENT
Title Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Investigational new drugs
Date of publication, distribution, etc. 10 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1463-1471 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Healthy Volunteers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hearing Loss
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injection, Intratympanic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thiosulfates
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shi, Fuxin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hu, Qi-Ying
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ren, Yong
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Keilty, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wolff, Heather
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McCarthy, Ryan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kropp, Jason
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weber, Pete
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Soglia, John
773 0# - HOST ITEM ENTRY
Title Investigational new drugs
Related parts vol. 38
-- no. 5
-- p. 1463-1471
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s10637-020-00918-1">https://doi.org/10.1007/s10637-020-00918-1</a>
Public note Available from publisher's website

No items available.